HemosepVet

Cell salvage of blood components

The Hemosep device concentrates blood by removing the fluid component, the plasma, from blood salvaged during or at the end of surgery.

Hemosep relies upon two main elements for its primary function of concentrating blood cells. These components are the control membrane and the superabsorber pad.

Decreased need for donor blood and associated blood products. This leads to a reduction in donor dependency, lessens the risk of contamination and reaction, whilst assisting in the decrease of post-operative bleeding. The result, is an improved animal recovery. 

Returning not only the RBCs, but the platelets, WBCs and residual clotting agents, aiding in the reduction in inflammatory molecules, resulting in a reduction in post-operative complications and maintenance of platelet population means there is preservation of normal clotting function.

• The animal receives its own blood rather than a plasma substitute, fresh frozen donor plasma or donor plasma cells
• Stabilised recovery time and the reduced risk of rejection
• Major cost savings vs alternative methods
• Solving the problems of:
  • The shortage of blood replacement products on the market
  • Blood from the Pet Blood Bank is becoming more expensive and harder to obtain

The Hemosep device concentrates blood by removing the fluid component of whole blood, the plasma, from a pooled volume of blood salvaged during, or at the end of high blood loss surgery. The technique for removing the plasma from the blood product, leading to concentration of the cellular components, is fairly simple but involves a number of critical steps and controls.

The Hemosep device consists of:

• The Hemosep bag
• Hemosep Shaker Unit
• A blood collection bag for the collection of processed blood
• Intraoperative pump, suction and blood reservoir